OneSource Specialty Pharma (NSE:ONESOURCE) Net Margin %: 5.57% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ONESOURCE OneSource Specialty Pharma Ltd NSE:ONESOURCE
8 GF Score
Price ₹1,483.60
! 3 Warning Signs
View Full Analysis

What is OneSource Specialty Pharma Net Margin %?

OneSource Specialty Pharma NSE:ONESOURCE -2.14% 8 Net Margin % is 5.57% as of Jun. 2026. GuruFocus rates NSE:ONESOURCE with a GF Score™ of 8/100. The stock has 3 warning signs investors should review. Among 942 Biotechnology companies, OneSource Specialty Pharma ranks better than 67.94% on this metric.

Net margin is calculated as Net Income divided by its Revenue. OneSource Specialty Pharma's Net Income for the three months ended in Jun. 2026 was ₹250 Mil. OneSource Specialty Pharma's Revenue for the three months ended in Jun. 2026 was ₹4,490 Mil. Therefore, OneSource Specialty Pharma's net margin for the quarter that ended in Jun. 2026 was 5.57%.

The historical rank and industry rank for OneSource Specialty Pharma's Net Margin % or its related term are showing as below:

NSE:ONESOURCE' s Net Margin % Range Over the Past 10 Years
Min: -2066   Med: -116.36   Max: -1.24
Current: -3.15

NSE:ONESOURCE's Net Margin % is ranked better than
67.94% of 942 companies
in the Biotechnology industry
Industry Median: -77.59 vs NSE:ONESOURCE: -3.15

OneSource Specialty Pharma  (NSE:ONESOURCE) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

OneSource Specialty Pharma Net Margin % Related Terms

OneSource Specialty Pharma Net Margin % Historical Data

* Premium members only.

The historical data trend for OneSource Specialty Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OneSource Specialty Pharma Net Margin % Chart

OneSource Specialty Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Net Margin %
-2,066.00 -227.53 -1.24 -5.19

OneSource Specialty Pharma Quarterly Data
Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.06 2.79 -30.55 1.07 5.57

NSE:ONESOURCE vs VRTX, REGN, RVMD: Net Margin % Comparison

For the Biotechnology subindustry, OneSource Specialty Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OneSource Specialty Pharma Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OneSource Specialty Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where OneSource Specialty Pharma's Net Margin % falls into.


NSE:ONESOURCE
8GF Score
OneSource Specialty Pharma Ltd NSE:ONESOURCE
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OneSource Specialty Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

OneSource Specialty Pharma's Net Margin for the fiscal year that ended in Mar. 2026 is calculated as

Net Margin=Net Income (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-738.03/14215.9
=-5.19 %

OneSource Specialty Pharma's Net Margin for the quarter that ended in Jun. 2026 is calculated as

Net Margin=Net Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=249.97/4490.23
=5.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 5.57% mean?
OneSource Specialty Pharma (NSE:ONESOURCE) has a Net Margin % of 5.57% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on OneSource Specialty Pharma and its competitors. According to the industry distribution chart, OneSource Specialty Pharma ranks #302 out of 942 companies in the Biotechnology industry, placing it in the top 32.1%.
Is OneSource Specialty Pharma's Net Margin % too high?
OneSource Specialty Pharma's current Net Margin % is 5.57%. Based on the distribution chart, OneSource Specialty Pharma ranks #302 out of 942 companies in the Biotechnology industry, which is above the industry midpoint. Overall, OneSource Specialty Pharma has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does OneSource Specialty Pharma's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, OneSource Specialty Pharma ranks #302 out of 942 companies for Net Margin %. This puts OneSource Specialty Pharma in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on OneSource Specialty Pharma and its competitors. OneSource Specialty Pharma's current Net Margin % is 5.57%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OneSource Specialty Pharma stock overvalued right now?
OneSource Specialty Pharma (NSE:ONESOURCE) has a current Net Margin % of 5.57%. The current Net Margin % is 5.57%. OneSource Specialty Pharma's overall GF Score™ is 8/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For OneSource Specialty Pharma (NSE:ONESOURCE), the current Net Margin % is 5.57% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OneSource Specialty Pharma Business Description

Other Exchanges 544292:India
Address Bannerghatta Road, Star 1, Opp IIM Bangalore, Bilekahalli, Bangalore, KA, IND, 560076
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
8GF Score

Get the complete analysis for NSE:ONESOURCE

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,483.60
Price